US FDA sends warning letter to Cardinal Health for marketing unapproved devices
The U.S. health regulator has sent a warning letter to Cardinal Health (CAH.N) after an inspection of its facility in Illinois found the company was marketing and distributing unapproved devices made by a Chinese manufacturer.